Time delays in the diagnosis and treatment of acute myocardial infarction: A tale of eight cities Report from the Pre-hospital Study Group and the Cincinnati Heart Project
- 1 October 1990
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 120 (4), 773-780
- https://doi.org/10.1016/0002-8703(90)90192-z
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Enhancing thrombolytic efficacy by means of “front-loaded” administration of tissue plasminogen activatorJournal of the American College of Cardiology, 1989
- Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activatorJournal of the American College of Cardiology, 1989
- Delay between onset of chest pain and seeking medical care: The effect of public educationAnnals of Emergency Medicine, 1989
- A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction.Circulation, 1989
- Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction.Circulation, 1988
- Thrombolysis and angioplasty in myocardial infarction (TAMI) trialJournal of the American College of Cardiology, 1987
- A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- Early thrombolysis in acute myocardial infarction: Limitation of infarct size and improved survivalJournal of the American College of Cardiology, 1986
- Prevention of Myocardial Damage in Acute Myocardial Ischemia by Early Treatment with Intravenous StreptokinaseNew England Journal of Medicine, 1985
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985